Sulfamerazine
Specifications
127-79-7CAS Number
204-866-2EC Number
4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamideIUPAC Name
C11H12N4O2SChemical Formula
264.31 g/molMolecular Weight
sulfamerazine; 127-79-7; Sulphamerazine; Sulfamethyldiazine; Mesulfa; 4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide; Percoccide; Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-; Septacil; Septosyl; Solumedin; 2-Sulfa-4-methylpyrimidine; N-(4-Methyl-2-pyrimidyl)sulfanilamide; 2-(Sulfanilamido)-4-methylpyrimidine; 2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine; 4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide; DTXSID0023612; (p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin; 4-amino-N-(4-methylpyrimidin-2-yl)benzene-1-sulfonamide; UR1SAB295F; NSC-27259; N(sup 1)-(4-Methyl-2-pyrimidinyl)sulfanilamide; CHEBI:102130; N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide; 2-(p-Aminobenzolsulfonamido)-4-methylpyrimidine; DTXCID603612; Methypyrimal; Sumedin; Monomethylsulfadiazine; RefChem:56065; SULFAMERAZINE FISH GRADE; 204-866-2; Methylsulfadiazine; Sulfamerazin; Cremomerazine; Methylpyrimal; Methylsulfazine; Sulfameradine; Pyralcid; Sumedine; Mebacid; Metilsulfadiazin; Veta-Merazine; Pyrimal M; Metilsulfazin; Sulfamerazina; Kelamerazine; Romezin; Debenal-M; Pirimal-M; Methylsulfazin; Sulfamerazinum; 2643-RP; RP 2632; N1-(4-Methyl-2-pyrimidinyl)sulfanilamide; A-310; 2-Sulfanilamido-4-methylpyrimidine; NSC 27259; Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-; Solumedine; Sulfamerazine (INN); 2632 R. P.; MFCD00023212; RP2632; MLS000551747; Solfamerazina; Sulfanilamide, N(sup 1)-(4-methyl-2-pyrimidinyl)-; NCGC00016386-01; CAS-127-79-7; SMR000145672; TRISULFAPYRIMIDINES (SULFAMERAZINE); Solfamerazina [DCIT]; SULFAMERAZINE [INN]; Sulfamerazinum [INN-Latin]; Sulfamerazina [INN-Spanish]; 4-Amino-N-(4-methyl-pyrimidin-2-yl)-benzenesulfonamide; 4-amino-N-(4-methylpyrimidin-2-yl); 4-Amino-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide; SR-01000684857; EINECS 204-866-2; UNII-UR1SAB295F; [(4-aminophenyl)sulfonyl](4-methylpyrimidin-2-yl)amine; BRN 0249133; ulfamerazine; AI3-08026; Sulfamerazine [USP:INN:BAN]; (p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin [German]; Sulfamerazine CRS; Prestwick_17; 4-Amino-N-(4-methyl-2-pyrimidyl)benzenesulfonamide; Sulfamerazine; Sulfadimidine Imp. A (Pharmeuropa); Sulfadimidine Impurity A; 4-Methylsulfadiazine;; Spectrum_000003; Opera_ID_988; Sulfamerazine (Standard); Prestwick0_000694; Prestwick1_000694; Prestwick2_000694; Prestwick3_000694; Spectrum2_001320; Spectrum3_001363; Spectrum4_000343; Spectrum5_001413; 2(p-Aminobenzolsulfonamido)-4-methylpyrimidin; SULFAMERAZINE [MI]; CHEMBL438; Epitope ID:122236; N(sup1)-(4-Methyl-2-pyrimidinyl)sulfanilamide; Sulfadimidine EP Impurity A; SCHEMBL33999; BSPBio_000847; BSPBio_002886; KBioGR_000745; KBioSS_000343; SULFAMERAZINE [VANDF]; 5-25-10-00167 (Beilstein Handbook Reference); MLS001201765; DivK1c_000563; SPECTRUM1500547; SULFAMERAZINE [MART.]; SPBio_001419; SPBio_002768; SULFAMERAZINE [USP-RS]; SULFAMERAZINE [WHO-DD]; BPBio1_000933; orb1226619; orb1310174; orb3140134; SCHEMBL29538415; GTPL12640; HMS501M05; HY-B0512R; KBio1_000563; KBio2_000343; KBio2_002911; KBio2_005479; KBio3_002106; MSK4002; NINDS_000563; GLXC-08058; HMS1570K09; HMS1921A15; HMS2092I17; HMS2097K09; HMS2234D16; HMS3374K04; HMS3652I03; HMS3714K09; HMS5081G18; Pharmakon1600-01500547; SULFAMERAZINE [GREEN BOOK]; SULFAMERAZINE [ORANGE BOOK]; ALBB-025702; HY-B0512; NSC27259; 2-Sulfanilamido-4-methylpyrimidine;; SULFAMERAZINE [EP MONOGRAPH]; Tox21_110411; BBL003544; CCG-39258; EBC-03812; MSK4002-100M; NSC757325; s3132; SBB057970; STK520614; SULFOSE COMPONENT SULFAMERAZINE; AKOS005143010; MSK4002-1000M; TERFONYL COMPONENT SULFAMERAZINE; Tox21_110411_1; DB01581; KS-5323; NSC-757325; IDI1_000563; LANTRISUL COMPONENT SULFAMERAZINE; pyrimidine, 4-methyl-2-sulphanilamido-; SULFALOID COMPONENT SULFAMERAZINE; NCGC00016386-02; NCGC00016386-03; NCGC00016386-06; NCGC00094787-01; NCGC00094787-02; NEOTRIZINE COMPONENT SULFAMERAZINE; FA133240; N'-(4-Methyl-2-pyrimidyl) sulfanilamide; SULFAMERAZINE (TRISULFAPYRIMIDINES); SBI-0051521.P003; Sulfamerazine 100 |Ig/mL in Acetonitrile; DB-041873; Sulfamerazine, ReagentPlus(R), >=99.0%; AB00052096; NS00000004; ST45028776; Sulfamerazine 100 microg/mL in Acetonitrile; SW196334-3; T0913; TRIPLE SULFOID COMPONENT SULFAMERAZINE; SULFADIMIDINE IMPURITY A [EP IMPURITY]; Sulfamerazine 1000 microg/mL in Acetonitrile; Sulfamerazine Solution in Methanol, 100ug/mL; Sulfamerazine, Vetec(TM) reagent grade, 98%; 2-(p-Aminobenzosulfonamido)-4-methylpyrimidine; D02435; D84140; EN300-202655; Sulfamerazine Solution in Methanol, 1000ug/mL; AB00052096-13; AB00052096_15; AB00052096_16; F375115; Q415196; Sulfamerazine, VETRANAL(TM), analytical standard; SR-01000684857-2; SR-01000684857-4; BRD-K93524252-001-05-6; BRD-K93524252-001-15-5; BRD-K93524252-001-23-9; BRD-K93524252-001-24-7; F2190-0484; N(SUP 1)-(4-METHYL-2- PYRIMIDINYL)SULFANILAMIDE; TRISULFAPYRIMIDINES (SULFAMERAZINE) [ORANGE BOOK]; Z1954804578; benzenesulfonamide, 4-amino-N(S)-(4-methylpyrimidin-2-yl)-; Sulfamerazine, European Pharmacopoeia (EP) Reference Standard; Sulfamerazine, United States Pharmacopeia (USP) Reference Standard; Sulfamerazine, Pharmaceutical Secondary Standard; Certified Reference MaterialSynonyms